Literature DB >> 3052364

Orthotopic liver transplantation for biliary atresia. Evolution of management.

J M Millis1, J J Brems, J R Hiatt, A S Klein, T Ashizawa, K P Ramming, W J Quinones-Baldrich, R W Busuttil.   

Abstract

Forty-five patients with biliary atresia were accepted for orthotopic liver transplantation. Nine patients died awaiting transplantation, and 36 underwent transplantation. A portoenterostomy had been performed in 28 of these 36 patients, and its presence did not significantly affect the intraoperative blood loss (5.6 vs 4.1 blood volumes), the need for retransplantation (21% vs 12%), biliary complications (21% vs 12%), postoperative infections (36% vs 25%), or survival (82% vs 63%). These results indicate that early portoenterostomy is appropriate early therapy for biliary atresia; however, prompt referral to a liver transplant center for evaluation at the first sign of cholestasis is needed to attain optimal results for transplantation. Revisions of the portoenterostomy prior to transplantation did not improve the longevity of the procedure but did substantially increase complications and death after orthotopic liver transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3052364     DOI: 10.1001/archsurg.1988.01400340063011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  11 in total

1.  Indication for redo hepatic portoenterostomy for insufficient bile drainage in biliary atresia: re-evaluation in the era of liver transplantation.

Authors:  T Hasegawa; T Kimura; T Sasaki; A Okada; S Mushiake
Journal:  Pediatr Surg Int       Date:  2003-04-03       Impact factor: 1.827

2.  Biliary Complication in Pediatric Liver Transplantation: a Single-Center 15-Year Experience.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  J Gastrointest Surg       Date:  2019-01-10       Impact factor: 3.452

3.  Primary Liver Transplantation vs. Transplant after Kasai Portoenterostomy for Infants with Biliary Atresia.

Authors:  Caroline P Lemoine; John P LeShock; Katherine A Brandt; Riccardo Superina
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

4.  Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience.

Authors:  J A Goss; C R Shackleton; K Swenson; N L Satou; B J Nuesse; D K Imagawa; M M Kinkhabwala; P Seu; J S Markowitz; S M Rudich; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

5.  A long-term experience with biliary atresia. Reassessment of prognostic factors.

Authors:  D U Tagge; E P Tagge; R A Drongowski; K T Oldham; A G Coran
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

Review 6.  Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.

Authors:  Shikha S Sundaram; Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

7.  Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications.

Authors:  Yukiko Takahashi; Yuko Nishimoto; Toshiharu Matsuura; Makoto Hayashida; Tatsuro Tajiri; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

8.  Evaluation, operative management, and outcome after liver transplantation in children with biliary atresia and situs inversus.

Authors:  D G Farmer; A Shaked; K M Olthoff; D K Imagawa; J M Millis; R W Busuttil
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

9.  Liver transplantation in children.

Authors:  R W Busuttil; P Seu; J M Millis; K M Olthoff; J R Hiatt; A Milewicz; B Nuesse; G el-Khoury; D Raybould; A Nyerges
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

Review 10.  Redo surgery for biliary atresia.

Authors:  Masaki Nio; Hideyuki Sasaki; Hiromu Tanaka; Atsushi Okamura
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.